Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1–AMPK signaling and autophagy
Authors:
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1852 (2) , 290-298
Abstract
No abstract availableKeywords
Funding Information
- NIH (NCRR 5P20RR016474)
- NIH (NIGMS 8P20GM103432)
This publication has 52 references indexed in Scilit:
- Striking a Balance: Autophagy, Apoptosis, and Necrosis in a Normal and Failing HeartCurrent Hypertension Reports, 2012
- Unmasking the janus faces of autophagy in obesity‐associated insulin resistance and cardiac dysfunctionClinical and Experimental Pharmacology and Physiology, 2012
- AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathyAutophagy, 2011
- Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 MiceDiabetes, 2011
- Activated protein C protects against myocardial ischemic/reperfusion injury through AMP‐activated protein kinase signalingJournal of Thrombosis and Haemostasis, 2011
- Impaired Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Activation and Ischemic Recovery in the Senescent HeartCirculation, 2010
- Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and functionProceedings of the National Academy of Sciences, 2009
- Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stressCardiovascular Research, 2008
- Effects of chronic Akt activation on glucose uptake in the heartAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling PathwaysCell, 2002